Healthcare & life sciences coverage

chapter 11 and restructuring coverage across Healthcare & life sciences.

108 articles

Showing 37 to 48 of 108 coverage articles

Week of March 16, 2026

Mercy Hospital Iowa City: Bondholder Fight Ended in Liquidation

Mercy Hospital Iowa City, a nonprofit hospital, filed chapter 11 after a bondholder receivership fight, sold substantially all assets to the University of Iowa for $28 million, and confirmed a liquidating plan projecting 77%-97% recoveries for bondholders and 8%-10% for unsecured and pension claims.

Healthcare & life sciences

Mar 19

American Physician Partners: Liquidating Plan Confirmed After Staffing Wind-Down

American Physician Partners filed chapter 11 in Delaware after unwinding roughly 150 emergency department and hospitalist contracts. The case focused on receivables, cash collateral disputes, a Cascade Capital sale, and a liquidating plan confirmed in March 2024.

Healthcare & life sciences

Mar 19

Eye Care Leaders: Ransomware, 363 Sale, Creditor Trust

Eye Care Leaders filed chapter 11 in the Northern District of Texas after ransomware fallout, customer attrition, and liquidity strain. The case centered on a fast section 363 sale and ended with a confirmed liquidating plan that transferred remaining assets into the ECL Creditor Trust.

Healthcare & life sciences

Mar 19

Platinum Heights: Heights Hospital Plan Collapse in Chapter 11

Platinum Heights filed chapter 11 Feb. 20, 2025 in S.D. Texas; a sale-backed plan was confirmed but failed to go effective.

Healthcare & life sciences

Mar 19

Invitae: NVTA Stock and $239M Labcorp Sale

Invitae filed chapter 11 in New Jersey with $1B+ liabilities, then sold its genetic testing business to Labcorp for $239M after a court-supervised auction.

Healthcare & life sciences

Mar 19

Eiger BioPharmaceuticals: $45.2M Sale and Rare Equity Recovery

Eiger filed chapter 11 April 2024; sold Zokinvy for $45.2M and avexitide for $35.1M. Rare outcome: equity holders received distributions.

Healthcare & life sciences

Mar 19

DermTech: Melanoma Patch Test Maker Sold After Chapter 11 Filing

DermTech filed chapter 11 June 2024; sold melanoma patch test business to DERM-JES Holdings. Liquidating plan estimates 39-55% GUC recovery.

Healthcare & life sciences

Mar 19

NanoString Technologies: Litigation-Driven 363 Sale and $392.6M Bruker Acquisition

NanoString filed chapter 11 in Delaware after 10x Genomics patent litigation strained liquidity. Bruker Corporation won the 363 auction at $392.6M, a 78% premium over the $220M stalking horse. The plan confirmed June 2024 with 100% projected GUC recovery.

Healthcare & life sciences

Mar 19

Azzur Group: Pandemic Cleanroom Bet Ends in $72M Liquidation

Life sciences consulting and cleanroom provider Azzur Group filed chapter 11 in Delaware after its Baird Capital-backed cleanroom expansion failed post-pandemic. Three 363 sales totaled $72.6M; the confirmed liquidating plan returned ~2.1% to unsecured creditors.

Healthcare & life sciences

Mar 16

Envision Healthcare: Dual-Silo Chapter 11 Reorganization

Envision Healthcare's chapter 11 reorganized the AmSurg and EVPS silos separately after KKR's 2018 buyout left the physician staffing group overleveraged amid No Surprises Act pressure, reimbursement cuts, labor inflation, and COVID-era disruption.

PrenegotiatedHealthcare & life sciences

Mar 16

Amyris: $1.15B Debt Cut in B2B Reorganization

Amyris used chapter 11 to shed about $1 billion of debt, sell seven consumer brands for about $29.6 million, and emerge as a B2B-focused 'Amyris 2.0' built around its retained Lab-to-Market platform.

FreefallConsumer & retail

Mar 16

InVivo Therapeutics: Failed Trial, Full Creditor Recovery

InVivo Therapeutics filed chapter 11 in Delaware after its INSPIRE 2.0 spinal cord injury trial failed. The cases used a 363 sale to Globus Medical and a liquidating plan that paid creditors in full before a later equity distribution.

Healthcare & life sciences

8

9